Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03922360 · ClinicalTrials.gov registry record · NA

Smartphone-based Financial Incentives

A NA study, sponsored by University of Vermont.

Completed
Registry status
NA
Development phase
150
Enrollment target

NCT03922360 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 150 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03922360, a NA study, has completed, sponsored by University of Vermont.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

Cigarette smoking during pregnancy increases risk for catastrophic pregnancy complications, growth retardation, other adverse fetal and infant health problems, and later-in-life chronic conditions among exposed offspring. The most effective intervention for reducing smoking during pregnancy is financial incentives whereby participants earn incentives (e.g., gift cards, cash) contingent on objective evidence of smoking abstinence. However, financial incentives-based interventions are typically delivered in relatively intense protocols requiring frequent clinic visits, which limits the geographical range over which services can be delivered and potentially denies treatment to those residing in remote or otherwise difficult to reach settings. The present study will examine the feasibility, efficacy, and cost-effectiveness of a smartphone-based financial incentives intervention whereby smoking monitoring and delivery of incentives are completed remotely using a mobile app (to be designed by DynamiCare Health, Inc.). Eligible participants who complete the informed consent process will be randomized to one of two conditions: an incentives condition wherein women will receive financial incentives contingent on the remote submission of breath and saliva specimens indicating abstinence from recent smoking (described below), or a best practices control condition in which women will receive usual care for smoking cessation that is provided at their obstetrical clinics, as well as three brief educational sessions and referral to the Vermont (or other state) pregnancy-specific quit line by our research staff. For inclusion in the study, women must meet the following criteria: (a) \> 18 years of age, (b) report being smokers at the time they learned of the current pregnancy, (c) report smoking in the 7 days prior to completing their phone eligibility screening, (c) \< 25 weeks pregnant, (d) speak English, (e) own a smartphone (Android or iOS; 81.8% of pregnant women in wave 1 \

Interventions

  • BEHAVIORAL Smartphone-based Financial Incentives
  • BEHAVIORAL Best Practices

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2019-04-01
Est. Completion 2021-06-16
Phase NA

Sponsor

University of Vermont

162 total trials

What the Registry Record Tells You About NCT03922360

The ClinicalTrials.gov registry entry for NCT03922360 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Smartphone-based Financial Incentives is the first listed.

NCT03922360 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03922360 about?

NCT03922360 is a clinical study titled "Smartphone-based Financial Incentives". Cigarette smoking during pregnancy increases risk for catastrophic pregnancy complications, growth retardation, other adverse fetal and infant health problems, and later-in-life chronic conditions among exposed offspring. The most effective intervention for reducing smoking during pregnancy is finan...

What is the current status of trial NCT03922360?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2019-04-01. Estimated completion is 2021-06-16.

What interventions are being tested in trial NCT03922360?

The interventions under investigation include: Smartphone-based Financial Incentives (BEHAVIORAL), Best Practices (BEHAVIORAL).

Who is sponsoring clinical trial NCT03922360?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.